A Novel Nuclear Role for the Vav3 Nucleotide Exchange Factor in Androgen Receptor Coactivation in Prostate Cancer

Oncogene - United Kingdom
doi 10.1038/onc.2011.273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Clinical Significance of Increased Guanine Nucleotide Exchange Factor Vav3 Expression in Human Gastric Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2012English

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2011English

Discovery and Mechanistic Characterization of a Novel Selective Nuclear Androgen Receptor Exporter for the Treatment of Prostate Cancer

Cancer Research
Cancer ResearchOncology
2010English

Identification of ETS-like Transcription Factor 4 as a Novel Androgen Receptor Target in Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

The Role of Alcohol-Induced Golgi Fragmentation for Androgen Receptor Signaling in Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2018English

TAF1, From a General Transcription Factor to Modulator of Androgen Receptor in Prostate Cancer

2008English

The Androgen Receptor and Prostate Cancer Invasion

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy